About PAREXEL Early Phase Clinical Unit
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Astellas Pharma Europe B.V.
9
Astellas Pharma Global Development, Inc.
5
Bial - Portela C S.A.
3
Heptares Therapeutics Limited
3
Medivir
2
Samsung Bioepis Co., Ltd.
2
Vantia Ltd
2
B. Braun Medical Inc.
1
Berlin Cures GmbH
1
Chinook Therapeutics, Inc.
1
Elixiron Immunotherapeutics Inc.
1
Clinical Trials at PAREXEL Early Phase Clinical Unit
During the past decade, PAREXEL Early Phase Clinical Unit conducted 24 clinical trials. In the 10-year time frame, 24 clinical trials started and 3 clinical trials were completed, i.e. on
average, 12.5% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 1 clinical trials were completed. i.e. 20%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Safety and Tolerability Study of N6022 in Healthy Subjects
2010-08-01
2011-06-01
Completed
41
Repeat Dose Tolerance Study of Regadenoson in Healthy Subjects
2013-05-01
2013-08-01
Completed
36
A Study to Assess the Relative Bioavailability Between Two ASP015K Tablets and the Food Effect of a New Tablet in Healthy Adult Subjects
2013-05-01
2013-08-01
Completed
36
A Study to Evaluate the Effect of Multiple Doses of Isavuconazole on the Pharmacokinetics of Repaglinide and Caffeine
2014-01-01
2014-02-01
Completed
24
A Study to Evaluate the Effect of Multiple Doses of Esomeprazole on the Pharmacokinetics of Isavuconazole
2014-01-01
2014-02-01
Completed
24
Study of the Pharmacokinetics and Safety of Tasimelteon in Children and Adolescents
2016-09-01
Unknown status
24
Evaluate the Safety Pharmacokinetics of a Human Monoclonal Antibody S315 Against Diphtheria Toxin in Healthy Subjects
2019-04-23
2019-10-07
Completed
41
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "PAREXEL Early Phase Clinical Unit" #1 sponsor was "Astellas Pharma Europe B.V." with 9 trials, followed by "Bial - Portela C S.A." with 3 trials
sponsored, "Heptares Therapeutics Limited" with 3 trials sponsored, "Medivir" with 2 trials sponsored and "Samsung Bioepis Co., Ltd."
with 2 trials sponsored. Other sponsors include 13 different institutions and
companies that sponsored additional 22 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "PAREXEL Early Phase Clinical Unit"
#1 collaborator was "Parexel" with 4 trials as a collaborator, "KCAS" with 1 trials as a collaborator, "Medical Research Council" with 1 trials as a collaborator and "Novartis Vaccines" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were
collaborators in the rest 4 trials.
Clinical Trials Conditions at PAREXEL Early Phase Clinical Unit
According to Clinical.Site data, the most researched conditions in "PAREXEL Early Phase Clinical Unit" are
"Healthy" (9 trials), "Healthy Subjects" (7 trials), "Healthy Volunteers" (4 trials), "Pharmacokinetics" (3 trials) and "Pulmonary Arterial Hypertension" (3 trials). Many other conditions were trialed in "PAREXEL Early Phase Clinical Unit" in a lesser frequency.
Clinical Trials Intervention Types at PAREXEL Early Phase Clinical Unit
Most popular intervention types in "PAREXEL Early Phase Clinical Unit" are "Drug" (35 trials) and "Biological" (2 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (9 trials), "ASP3652" (3 trials), "BIA 5-1058" (3 trials), "EC905" (2 trials) and "Itraconazole" (2 trials). Other intervention names were less common.
Clinical Trials Genders at PAREXEL Early Phase Clinical Unit
The vast majority of trials in "PAREXEL Early Phase Clinical Unit" are
23 trials for "All" genders and 14 trials for "Male" genders.
Clinical Trials Status at PAREXEL Early Phase Clinical Unit
Currently, there are NaN active trials in "PAREXEL Early Phase Clinical Unit".
undefined are not yet recruiting,
undefined are recruiting,
1 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 32 completed trials in PAREXEL Early Phase Clinical Unit,
undefined suspended trials,
and 2 terminated clinical trials to date.
Out of the total trials that were conducted in PAREXEL Early Phase Clinical Unit, 34 "Phase 1"
clinical trials were conducted, 4 "Phase 2" clinical
trials and 0 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".